Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 2

Conditions: Post-Menopausal Osteoporosis

Treatments: Drug: MK0429

Study type: Interventional

Funder types: Industry

Identifiers

NCT00533650

2007_620

0429-005

Details and patient eligibility

About

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Enrollment: 227 patients

Sex: Female

Ages: 50 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis

Exclusion criteria

• Person has had a previous fracture
• Person has rheumatoid arthritis. Person has has certain types of cancer
• Person has donated blood or has been in another investigational study within the last 4 weeks

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind